For years, Kasia Lipska, MD, MHS, associate professor of medicine (endocrinology) at Yale School of Medicine (YSM), has been ...
The director of preventive cardiology at the University of Michigan, says the medications are a promising option for many ...
Many researchers think that Wegovy and Ozempic should be taken for life, but myriad factors can force people off them.
The North Carolina state treasurer is taking on drugmakers Novo Nordisk and Eli Lilly in an attempt to lower drug costs for ...
While the benefits are substantial, so too may be the costs as more and more drugs and patients receive coverage. Obesity prevalence ... prices for Wegovy , with a list price up to $1,349 and ...
Congressional leaders and the administration must work together to expand access to anti-obesity medications through Medicare ...
Less than half of large employers currently cover the new generation of obesity drugs, but an additional 18% say they’re considering adding them amid surging interest. Nov. 11, 2023 In some ...
Medscape Medical News, April 17, 2024 Amino Acid Supplement Cuts Liver Risks in PCOS and Obesity A proprietary essential amino ... Week in Cardiology Obesity drugs as ASCVD-modifiers, HR monitors ...
Ozempic and weight-loss drugs raise hopes for obesity, but complexities exist. The Ozempic buzz plays into ideas of fat stigma and fatphobia. The Ozempic doesn't work same for everyone.
LONDON — Following a nine-month investigation, European regulators said Friday they have found no evidence that GLP-1 drugs like Ozempic and Wegovy cause suicidal thoughts or actions. The ...
“It’s not all about weight loss,” he said, adding that semaglutide ... and often linked with obesity. The growing list of potential uses for obesity drugs has been driving up expectations ...
A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF ...